215 filings
Page 2 of 11
8-K
l4h3pj2s
4 May 22
Active Customer Sites Climb 17% to New Record
4:09pm
8-K
3jn20
23 Feb 22
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
4:34pm
8-K
ud7hqq 18b
13 Jan 22
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
7:30am
8-K
ory6hbt4
3 Dec 21
Changes in Registrant's Certifying Accountant
4:38pm
8-K
rmo5eph1
8 Oct 21
Nephros Announces Preliminary Results for Third Quarter of 2021
7:45am
8-K
vkagkuc hk8regrs
2 Sep 21
Nephros Appoints Wes Lobo to Chief Commercial Officer
8:53am
8-K
7c7sqjern4yd7 4i778q
5 Aug 21
Results of Operations and Financial Condition
4:27pm
8-K
5nhv23t3t
12 Jul 21
Strategic Acquisition Accelerates Pathogen Detection Product Development
10:30am
8-K
2w0ap dr5vw
8 Jul 21
Nephros Announces Preliminary Results for Second Quarter of 2021
9:22am
8-K
fzzuv23u4 a0
20 May 21
Departure of Directors or Certain Officers
5:20pm
8-K
auia4s
6 May 21
Net Revenue of $2.7 Million; Highest First Quarter in Company History
4:15pm
8-K
v698tqvyxctnh71g 9v
5 Apr 21
Nephros Announces Preliminary Results for First Quarter of 2021
7:47am
8-K
z994mc pz
31 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
z18xz8 aflilhgo8k70u
29 Mar 21
Other Events
5:15pm
8-K
zsbpedrbjklopx
1 Mar 21
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results
4:20pm
8-K
bdu9b4anya9k36acbho0
3 Feb 21
Departure of Directors or Certain Officers
5:10pm
8-K
szf 6q226
12 Jan 21
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
10:51am
8-K
0t3wym7usqcgfd
5 Nov 20
Nephros Appoints Dan D’Agostino as CFO
4:18pm
8-K
k82vxv 6vyjpbvtjj
29 Oct 20
Departure of Directors or Certain Officers
4:15pm
8-K
5gvhtug
20 Oct 20
Entry into a Material Definitive Agreement
4:15pm